Related Experiment Videos

Tumor-to-tumor metastasis to the central nervous system

Hidehiro Takei1, Suzanne Z Powell

  • 1Department of Pathology, The Methodist Hospital, 6565 Fannin Street, Houston, TX 77030, USA. takei327@aol.com

Insights

Tumor-to-tumor metastasis is rare. This study details two unique cases of cancer spreading to meningioma, including a lung adenocarcinoma and a vulvar malignant melanoma.

Area of Science:

  • Neuropathology
  • Oncology

Background:

  • Tumor-to-tumor metastasis is a recognized oncological event.
  • Meningiomas are the most frequent primary intracranial tumors acting as hosts for metastasis.
  • Breast and lung cancers are the most common primary sources of metastasis to the brain.

Observation:

  • Two cases of metastasis to meningioma are presented.
  • Case 1: Metastatic lung adenocarcinoma within a microcystic meningioma in a 69-year-old female.
  • Case 2: Metastatic malignant melanoma (MM) within a fibroblastic meningioma in a 75-year-old female.

Findings:

  • The first reported instance of metastatic carcinoma within a microcystic meningioma.
  • Metastasis from vulvar malignant melanoma to meningioma, though rare, is confirmed.
  • Both cases highlight the diverse histological subtypes of meningioma that can harbor metastatic disease.

Implications:

  • These cases expand the understanding of tumor-to-tumor metastasis involving meningiomas.
  • Highlights the importance of considering metastatic disease in the differential diagnosis of intracranial masses.
  • Underscores the potential for rare metastatic patterns, even in histologically distinct meningioma variants.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K